Cho JY

References (19)

Title : Population pharmacokinetic and pharmacodynamic model of evogliptin: Severe uremia increases the bioavailability of evogliptin - Kim_2024_CPT.Pharmacometrics.Syst.Pharmacol__
Author(s) : Kim B , Kim JE , Lee S , Oh J , Cho JY , Jang IJ , Chung JY , Yoon S
Ref : CPT Pharmacometrics Syst Pharmacol , : , 2024
Abstract :
PubMedSearch : Kim_2024_CPT.Pharmacometrics.Syst.Pharmacol__
PubMedID: 39465597

Title : Enhancement of debitterness, water-solubility, and neuroprotective effects of naringin by transglucosylation - Im_2023_Appl.Microbiol.Biotechnol__
Author(s) : Im AE , Eom S , Seong HJ , Kim H , Cho JY , Kim D , Lee JH , Yang KY , Nam SH
Ref : Applied Microbiology & Biotechnology , : , 2023
Abstract :
PubMedSearch : Im_2023_Appl.Microbiol.Biotechnol__
PubMedID: 37642718

Title : Revealing the key gene involved in bioplastic degradation from superior bioplastic degrader Bacillus sp. JY35 - Kim_2023_Int.J.Biol.Macromol_244_125298
Author(s) : Kim SH , Cho JY , Nara S , Hwang JH , Kim HJ , Oh SJ , Bhatia SK , Yun J , Lee SH , Yang YH
Ref : Int J Biol Macromol , 244 :125298 , 2023
Abstract :
PubMedSearch : Kim_2023_Int.J.Biol.Macromol_244_125298
PubMedID: 37315675
Gene_locus related to this paper: bacpu-q6rsn0

Title : Synthesis of ellagic acid glucoside using glucansucrase from Leuconostoc and characterization of this glucoside as a functional neuroprotective agent - Yu_2021_AMB.Express_11_108
Author(s) : Yu H , Jeong H , Yang KY , Cho JY , Hong IK , Nam SH
Ref : AMB Express , 11 :108 , 2021
Abstract :
PubMedSearch : Yu_2021_AMB.Express_11_108
PubMedID: 34287737

Title : Potential Regulatory Role of Human-Carboxylesterase-1 Glycosylation in Liver Cancer Cell Growth - Na_2020_J.Proteome.Res_19_4867
Author(s) : Na K , Kim M , Kim CY , Lim JS , Cho JY , Shin H , Lee HJ , Kang BJ , Han DH , Kim H , Baik JH , Swiatek-de Lange M , Karl J , Paik YK
Ref : J Proteome Res , 19 :4867 , 2020
Abstract :
PubMedSearch : Na_2020_J.Proteome.Res_19_4867
PubMedID: 33206527
Gene_locus related to this paper: human-CES1

Title : Comparison of scopolamine-induced cognitive impairment responses in three different ICR stocks - Yoon_2018_Lab.Anim.Res_34_317
Author(s) : Yoon WB , Choi HJ , Kim JE , Park JW , Kang MJ , Bae SJ , Lee YJ , Choi YS , Kim KS , Jung YS , Cho JY , Hwang DY , Song HK
Ref : Lab Anim Res , 34 :317 , 2018
Abstract :
PubMedSearch : Yoon_2018_Lab.Anim.Res_34_317
PubMedID: 30671121

Title : Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers - Jang_2017_Drug.Des.Devel.Ther_11_705
Author(s) : Jang K , Kim MK , Oh J , Lee S , Cho JY , Yu KS , Choi TK , Lee SH , Lim KS
Ref : Drug Des Devel Ther , 11 :705 , 2017
Abstract :
PubMedSearch : Jang_2017_Drug.Des.Devel.Ther_11_705
PubMedID: 28331290

Title : The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans - Oh_2017_PLoS.One_12_e0176320
Author(s) : Oh J , Lee S , Lee H , Cho JY , Yoon SH , Jang IJ , Yu KS , Lim KS
Ref : PLoS ONE , 12 :e0176320 , 2017
Abstract :
PubMedSearch : Oh_2017_PLoS.One_12_e0176320
PubMedID: 28437488

Title : Effects of renal impairment on the pharmacokinetics and pharmacodynamics of a novel dipeptidyl peptidase-4 inhibitor, evogliptin (DA-1229) - Oh_2017_Diabetes.Obes.Metab_19_294
Author(s) : Oh J , Kim AH , Lee S , Cho H , Kim YS , Bahng MY , Yoon SH , Cho JY , Jang IJ , Yu KS
Ref : Diabetes Obes Metab , 19 :294 , 2017
Abstract :
PubMedSearch : Oh_2017_Diabetes.Obes.Metab_19_294
PubMedID: 27761990

Title : Pharmacokinetic comparison using two tablets of an evogliptin\/metformin XR 2.5\/500 mg fixed dose combination vs. 1 tablet each of evogliptin 5 mg and metformin XR 1,000 mg - Yoon_2017_Int.J.Clin.Pharmacol.Ther_55_533
Author(s) : Yoon S , Rhee SJ , Park SI , Yoon SH , Cho JY , Jang IJ , Lee S , Yu KS
Ref : Int J Clinical Pharmacology & Therapeutics , 55 :533 , 2017
Abstract :
PubMedSearch : Yoon_2017_Int.J.Clin.Pharmacol.Ther_55_533
PubMedID: 28406090

Title : Pharmacokinetics of the evogliptin\/metformin extended-release (5\/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects - Rhee_2016_Drug.Des.Devel.Ther_10_1411
Author(s) : Rhee SJ , Lee S , Yoon SH , Cho JY , Jang IJ , Yu KS
Ref : Drug Des Devel Ther , 10 :1411 , 2016
Abstract :
PubMedSearch : Rhee_2016_Drug.Des.Devel.Ther_10_1411
PubMedID: 27110098

Title : Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects - Rhee_2016_Drug.Des.Devel.Ther_10_2525
Author(s) : Rhee SJ , Choi Y , Lee S , Oh J , Kim SJ , Yoon SH , Cho JY , Yu KS
Ref : Drug Des Devel Ther , 10 :2525 , 2016
Abstract :
PubMedSearch : Rhee_2016_Drug.Des.Devel.Ther_10_2525
PubMedID: 27570447

Title : Characterization of a novel cold-active esterase isolated from swamp sediment metagenome - Seo_2014_World.J.Microbiol.Biotechnol_30_879
Author(s) : Seo S , Lee YS , Yoon SH , Kim SJ , Cho JY , Hahn BS , Koo BS , Lee CM
Ref : World J Microbiol Biotechnol , 30 :879 , 2014
Abstract :
PubMedSearch : Seo_2014_World.J.Microbiol.Biotechnol_30_879
PubMedID: 24353039
Gene_locus related to this paper: 9bact-i3rtt4

Title : Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers - Gu_2014_Drug.Des.Devel.Ther_8_1709
Author(s) : Gu N , Park MK , Kim TE , Bahng MY , Lim KS , Cho SH , Yoon SH , Cho JY , Jang IJ , Yu KS
Ref : Drug Des Devel Ther , 8 :1709 , 2014
Abstract :
PubMedSearch : Gu_2014_Drug.Des.Devel.Ther_8_1709
PubMedID: 25336915

Title : Novel functional Renilla luciferase mutant provides long-term serum stability and high luminescence activity - Song_2013_Protein.Expr.Purif_91_215
Author(s) : Song WC , Sung HJ , Park KS , Choi JW , Cho JY , Um SH
Ref : Protein Expr Purif , 91 :215 , 2013
Abstract :
PubMedSearch : Song_2013_Protein.Expr.Purif_91_215
PubMedID: 23973867

Title : Pancreatic lipase inhibition by C-glycosidic flavones Isolated from Eremochloa ophiuroides - Lee_2010_Molecules_15_8251
Author(s) : Lee EM , Lee SS , Chung BY , Cho JY , Lee IC , Ahn SR , Jang SJ , Kim TH
Ref : Molecules , 15 :8251 , 2010
Abstract :
PubMedSearch : Lee_2010_Molecules_15_8251
PubMedID: 21081855

Title : Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers - Lim_2009_Br.J.Clin.Pharmacol_68_883
Author(s) : Lim KS , Cho JY , Kim BH , Kim JR , Kim HS , Kim DK , Kim SH , Yim HJ , Lee SH , Shin SG , Jang IJ , Yu KS
Ref : British Journal of Clinical Pharmacology , 68 :883 , 2009
Abstract :
PubMedSearch : Lim_2009_Br.J.Clin.Pharmacol_68_883
PubMedID: 20002082

Title : Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study - Lim_2008_Clin.Ther_30_1817
Author(s) : Lim KS , Kim JR , Choi YJ , Shin KH , Kim KP , Hong JH , Cho JY , Shin HS , Yu KS , Shin SG , Kwon OH , Hwang DM , Kim JA , Jang IJ
Ref : Clin Ther , 30 :1817 , 2008
Abstract :
PubMedSearch : Lim_2008_Clin.Ther_30_1817
PubMedID: 19014837

Title : Differential induction of hepatic microsomal epoxide hydrolase by alkyl sulphides and alkyl ethers in rat - Cho_1997_Xenobiotica_27_759
Author(s) : Cho JY , Kim SG
Ref : Xenobiotica , 27 :759 , 1997
Abstract :
PubMedSearch : Cho_1997_Xenobiotica_27_759
PubMedID: 9293614